Last edition
News about Regulation
Lupin Announces Resolution of US FDA Warning Letter for its Goa and Pithampur Facilities
This is after the satisfactory evaluation of the corrective actions taken by the company in response to the Warning Letter that was issued on November 6, 2017.
Regulation | 28/07/2023 | By Manvi | 779
Income Tax Survey at Ipca Laboratories Ltd's plants
The Income Tax Department has carried out survey proceedings at the Company's offices in Mumbai and at Sikkim manufacturing plants between 30th May, 2023 to 3rd June, 2023.
Regulation | 06/06/2023 | By Sudeep Soparkar | 564
US FDA Conducts GMP Inspection at Piramal Pharma's Digwal Facility
The inspection that was held from March 27 to 31 was completed successfully with Zero Form-483 observations.
Regulation | 05/04/2023 | By Manvi | 1274
Govt Cancels License of 18 Pharma Companies
As many as 76 pharma companies were inspected across 20 states/ UTs by a joint team of the state and central drug regulators.
Regulation | 05/04/2023 | By Manvi | 521
Cipla receives EIR for Indore plant
The inspection was conducted from June 27, 2022, to July 01, 2022.
Regulation | 23/09/2022 | By Sudeep Soparkar | 1005
LANXESS value change to become climate-neutral
Specialty chemicals company LANXESS is taking the next step in climate protection and has set a target for its scope 3 emissions
Regulation | 10/08/2022 | By Sudeep Soparkar | 710
Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants
Akums will get access to markets in the entire European Union as well as many other markets across the world.
Regulation | 01/07/2022 | By Sudeep Soparkar | 1704
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy